Milestones - i2medi

Doctor Ulises Rojel Martinez, president of the Latin American Heart Rhythm Society

First Publication on initial Latin American Experience with CCM technology

The teams of i2medi -the official distributor of impulse dynamics (the CCM manufacturer) in Mexico
have been successfully trained and certified in Feb 2024.

Mexico-Cardiac Contractility Modulation (CCM) expanding rapidly

The teams of i2medi -the official distributor of impulse dynamics (the CCM manufacturer) in Mexico
have been successfully trained and certified in Feb 2024.

First implantation of SmartOptimzer in Mexico

Dr. Ulises Rojel, implants the Optimizer Smart at the Instituto del Corazón in Puebla, Mexico.

Cardisio

i2medi and the prestigious cardiology team at the IGESP hospital in Sao Paulo are currently conducting the first AI-based Cardisio study in Latin America.

Successful CAAC certification Colombia

Since April 2023, i²medi S.A.S., based in Colombia, has been acting as an official importer of controlled and non-controlled medical devices in the Colombian market.

EMB use is recommended in the new Brazilian myocarditis guidelines.

Nachhaltigen und strategischen Produktpositionierung in den Schlüsselmärkten Lateinamerikas (BRA, COL und MEX) …

COFEPRIS MEX Regulatory approval

Am 15. März 2023 hat die mexikanische Behörde „COFEPRIS“, verantwortlich für die Produktzulassung neuer medizintechnischer Produkte, den Smart Optimizer des Unternehmens Impulse Dynamics – Klasse 3 – zugelassen.

Inclusion of CCM in the Brazilian guidelines for implantable electronic devices - 2023

The Brazilian Society of Cardiology recommends Cardiac Contractility Modulation (CCM) therapy as an option for the treatment of heart failure patients without indication for CRT, with narrow QRS (< 130 ms) and LVEF between 25% and 45%.

Implementation of scientific studies: i²medi / Impulse Dynamics sponderdern InCor study FIX Chagas HF

InCor (Instituto do Coração - Hospital of the University of São Paulo - HCFMUSP) initiates the world's first randomized clinical trial of Cardiac Contractility Modulation (CCM) in patients with Chagas disease.

Digital continuing education for the public health system

In Zusammenarbeit mit dem kolumbianischen Verband für Osteoporose ACOMM haben wir …

User training R.E.M.S. technology (Echolight)

Anwender-Schulung von 59 Teilnehmern zur R.E.M.S.-Technologie mit …

Development of return of investment calculation tools

Für das Unternehmen Caresyntax, OP-Video- und Datenintegrationssysteme, haben wir ein …

Coordinated studies First Latin American clinical trial of R.E.M.S. technology

First Software-as-a-Service (SAAS) sales contract for new OR performance management software in LATAM

i2medi has managed to successfully conclude the first contract with the most modern hospital for the treatment of cancer in LATAM (CTIC).

First implantation and commercial success with new technology in heart failure

i2medi hat den Vertrieb der Modulation der kardialen Kontraktilität in Brasilien …

Establishment and commercial usage of reference sites - Los Cobos - Bogotá

i2medi, together with its local strategic partners, organized a major launch event at the ...

Product approval class IIb in Mexico < than 6 months

Our local team in Mexico achieved product registration approval on the fly.

High 6-digit project profit in the area of hospital infrastructure